NCT00657319View on ClinicalTrials.gov

Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins

CompletedOBSERVATIONAL
Enrollment

3,495

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

April 30, 2008

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart 30

The observation is performed under normal clinical practice conditions without any additionally required diagnostic/therapeutic features. Physicians are allowed to decide the treatment regimen according to the medical standards.

Trial Locations (1)

1025

Novo Nordisk Investigational Site, Budapest

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY